BioProbe Diagnostics

Indonesia
Tangkanpulit, West Nusa Tenggara, Indonesia

Company profile

BioProbe Diagnostics company profile

BioProbe Diagnostics (BPD) is a spin out company from NUI Galway (NUIG) established in 2017. It has been established to commercialise novel Nucleic Acid Diagnostics (NAD) proprietary technologies for the detection and identification of microbial contaminants associated with the environmental and industrial sectors. BPD holds worldwide licenses for use of these technologies in the stated fields of application. The company has worked closely with NUIG to develop the nascent technology from the laboratory through to the market. BPD has a strong team of scientists, inventors and a business manager with prior proven success and experience in bringing new products to the market. The team is currently focused on the launch of the companies’ initial NAD product, namely Bio-Lp-1, which will add novel capability to Legionella testing.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $83,347 / 2018-06-01
Investors
1
Founders
1

Founders and investors

Founders

Ciaran Geoghegan

Investors

EISMEA